| New non-selective ER user vs. new non-selective IR user | New selective user vs. New non-selective IR user |
---|---|---|
OR (95% CI) | OR (95% CI) | |
Age Group | ||
 65 to 74 | Ref. | Ref. |
 75 to 84 | 1.044 (0.919–1.186) | 0.982 (0.826–1.167) |
 85 and Older | 0.857 (0.752–0.977)a | 0.888 (0.743–1.060) |
Female | 1.266 (1.130–1.418)a | 1.321 (1.132–1.541)a |
Race | ||
 White | Ref. | Ref. |
 Black | 1.288 (1.089–1.523)a | 0.894 (0.703–1.137) |
 Other Race | 1.062 (0.818–1.380) | 1.353 (0.952–1.923) |
Nursing Home Region | ||
 Midwest | Ref. | Ref. |
 Northeast | 0.624 (0.557–0.700)a | 0.562 (0.476–0.664)a |
 South | 0.647 (0.581–0.719)a | 1.052 (0.917–1.207) |
 West | 0.848 (0.708–1.016) | 0.622 (0.474–0.815)a |
Body Mass Index | ||
 Underweight | 0.779 (0.663–0.916)a | 0.673 (0.527–0.859)a |
 Normal | Ref. | Ref. |
 Overweight | 1.080 (0.971–1.202) | 1.181 (1.024–1.362)a |
 Obese | 1.346 (1.196–1.515)a | 1.319 (1.124–1.547)a |
Cognitive Performance Score | ||
 Intact | Ref. | Ref. |
 Borderline intact/Mild Impairment | 1.009 (0.895–1.137) | 1.057 (0.900–1.240) |
 Moderate impairment | 1.011 (0.886–1.154) | 0.937 (0.783–1.120) |
 Moderate-severe/Severe/Very Severe impairment | 0.549 (0.456–0.659)a | 0.512 (0.391–0.669)a |
CHESS | ||
 Score of 0 | Ref. | Ref. |
 Score of 1 or 2 | 0.940 (0.849–1.040) | 0.853 (0.745–0.977)a |
 Score of 3 | 0.727 (0.612–0.864)a | 0.837 (0.663–1.057) |
 Score of 4 or 5 | 0.685 (0.498–0.943)a | 0.835 (0.538–1.295) |
Activities of Daily Living | 0.989 (0.980–0.997)a | 0.976 (0.965–0.988)a |
Elixhauser/Other Comorbidities | ||
 Aphasia | 0.554 (0.411–0.746)a | 0.616 (0.399–0.951)a |
 Congestive Heart Failure | 0.831 (0.745–0.927)a | 0.834 (0.716–0.971)a |
 Hypertension, Uncomplicated | 1.282 (1.170–1.406)a | 1.037 (0.915–1.176) |
 Weight Loss | 0.777 (0.652–0.926)a | 0.772 (0.596–0.999)a |
Bladder Continence | ||
 Continent | Ref. | Ref. |
 Usually Continent | 1.235 (1.064–1.433)a | 1.076 (0.880–1.316) |
 Occasionally Incontinent | 1.575 (1.355–1.830)a | 1.495 (1.224–1.827)a |
 Frequently Incontinent | 1.524 (1.326–1.751)a | 1.503 (1.246–1.813)a |
 Incontinent | 1.083 (0.909–1.290) | 1.204 (0.936–1.550) |
No Bladder Continence Appliance or Program | 1.217 (1.081–1.371)a | 0.982 (0.836–1.153) |
Bowel Continence | ||
 Continent | Ref. | Ref. |
 Usually Continent | 0.741 (0.632–0.869)a | 0.936 (0.763–1.150) |
 Occasionally Incontinent | 0.938 (0.775–1.135) | 0.802 (0.617–1.042) |
 Frequently Incontinent | 0.759 (0.641–0.899)a | 0.626 (0.493–0.795)a |
 Incontinent | 0.688 (0.573–0.826)a | 0.582 (0.446–0.758)a |
Urinary Tract Infection in Last 30 Days | 1.119 (1.006–1.244)a | 1.197 (1.037–1.382)a |
Gait | ||
 Unsteady Gait | 1.140 (1.042–1.246)a | 1.017 (0.900–1.148) |
 Fell in Past 30 days | 1.193 (1.082–1.315)a | 1.072 (0.939–1.223) |
 Hip Fracture in Last 180 Days | 1.254 (1.047–1.502)a | 1.025 (0.778–1.333) |
 Other Fracture in Last 180 Days | 1.249 (1.060–1.472)a | 1.344 (1.071–1.662)a |
Balance While Sitting | ||
 Maintained position as required in test | Ref. | Ref. |
 Unsteady, but able to rebalance self without physical support | 1.043 (0.911–1.193) | 0.958 (0.796–1.152) |
 Partial physical support during test or stands but does not follow directions for test | 1.026 (0.896–1.174) | 0.866 (0.715–1.049) |
 Not able to attempt test without physical help | 0.883 (0.709–0.980)a | 0.700 (0.551–0.890)a |
Concomitant Medications | ||
 Calcium Channel Blockers | 1.014 (0.919–1.120) | 1.182 (1.036–1.349)a |
 Cognitive Enhancers | 1.031 (0.929–1.144) | 1.203 (1.047–1.382)a |
 Antiparkinson | 0.896 (0.774–1.038) | 1.372 (1.139–1.653)a |
 Antipsychotics | 0.476 (0.425–0.532)a | 0.874 (0.751–1.017) |
 Antivertigo | 0.269 (0.236–0.307)a | 0.727 (0.608–0.869)a |
 Anxiolytic Sedative or Hypnotic Agent | 0.672 (0.591–0.763)a | 1.015 (0.853–1.208) |
 Antidepressant | 0.597 (0.543–0.656)a | 1.315 (1.157–1.494)a |
 ARB | 1.024 (0.889–1.180) | 1.287 (1.077–1.538)a |
 Alpha Blockers | 1.024 (0.894–1.173) | 1.299 (1.088–1.553)a |
 Anticonvulsant | 0.719 (0.646–0.799)a | 0.935 (0.812–1.076) |
 Vasodilators | 0.595 (0.523–0.676)a | 1.024 (0.861–1.216) |
 Benzodiazepines | 2.249 (1.357–3.727)a | 1.694 (0.860–3.338) |
Anticholinergic Burden Score | 1.476 (1.443–1.510)a | 0.808 (0.780–0.836)a |